Table 1. Correlation between integrin β1 expression and clinicopathological parameters.
| Clinicopathological parameters | N (90) | Integrin β1 | X 2 | p | |
|---|---|---|---|---|---|
| Low expression (n) | High expression (n) | ||||
| Sex | |||||
| Male | 58 | 32 | 26 | 0.569 | 0.451 |
| Female | 32 | 15 | 17 | ||
| Age | |||||
| ≥60 | 54 | 25 | 29 | 1.900 | 0.168 |
| <60 | 36 | 22 | 14 | ||
| Tumor diameter (cm) | |||||
| ≥7 | 18 | 13 | 5 | 3.607 | 0.058 |
| <7 | 72 | 34 | 38 | ||
| T stage | |||||
| T3 + T4 | 77 | 41 | 36 | 0.224 | 0.636 |
| T1 + T2 | 13 | 6 | 7 | ||
| N stage | |||||
| N1-2 | 43 | 17 | 26 | 5.312 | 0.021 |
| N0 | 47 | 30 | 17 | ||
| M stage | |||||
| M1 | 4 | 1 | 3 | 0.345* | |
| M0 | 86 | 46 | 40 | ||
| AJCC stage | |||||
| III + IV | 44 | 18 | 26 | 4.416 | 0.036 |
| I + II | 46 | 29 | 17 | ||
| Vascular invasion | |||||
| Yes | 5 | 1 | 4 | 0.189* | |
| No | 85 | 46 | 39 | ||
Note: *Fisher’s exact test; AJCC, American Joint Committee on Cancer.